Sara Saif, a second-year student in Belmont University’s College of Pharmacy, was given the opportunity to conduct research in a polypharmacy project within the COVID-19 and Cancer Consortium (CCC-19), a consortium of more than 120 cancer centers and other organizations who have come together to collect data about patients with cancer who have been diagnosed with COVID-19.
This project aims to analyze and assess the impact of polypharmacy and select medication classes on COVID-19 outcomes among patients in the geriatric population who have or have had a diagnosis of cancer. By utilizing the CCC-19 registry database, a statistical analysis plan will be created for certain medication classes of interest.
Saif was invited to become a member of the research team because of her excellent work during the 2021 Biomedical Informatics internship at Vanderbilt University. By participating in this project, Sara will not only be using her clinical knowledge, but will also be using her knowledge of healthcare informatics and analytics to accurately assess and evaluate the clinical impact of certain medication classes on the geriatric population within the CCC-19 database registry.
Among others, Saif will be working with Dr. Christopher Jensen, MD, a Hematology/Oncology clinical fellow at the University of North Carolina; Dr. Samuel Rubinstein, MD, a Clinical Assistant Professor at the Division of Hematology University of North Carolina-Chapel Hill School of Medicine; Dr. Tanya Wildes, MD, MSCI; and Dr. Ariella Elkrief, MD, a Research Fellow.